ATNEC Breast Cancer Study

On #WorldCancerDay, our PPI rep Jan Rose reminds us why quality of life after breast cancer treatment matters. #ATNEC is exploring how optimising treatment may help reduce long-term side effects like lymphoedema. youtu.be/e8hJmUp_37k?si… @NIHRresearch @amit_goyalx @ICPVtweets

“It’s not just about surviving cancer - it’s about living well after.” Jan Rose (PPI rep) on lymphoedema and why the #ATNEC Trial matters. youtu.be/e8hJmUp_37k?si… @DerbyRandD @WarwickCTU @amit_goyalx @NIHRresearch @ICPVtweets @RTTQA_UK @jxbruce

Today, 24th October, is Wear it Pink day! To mark it, we wanted to thank all the hospital teams in the UK and Ireland working hard to support the ATNEC breast cancer trial. @DerbyRandD @WarwickCTU @amit_goyalx @RCSI_NSRSC @NIHRResearch @RTTQA_UK #ClinicalTrials #WearItPink

BIOSYM feasibility RCT (ADM vs synthetic mesh in breast reconstruction) has completed recruitment — 1st UK reconstruction trial to do so! 👏 Thanks to Derby, Nottingham, Hull, High Wycombe & Leicester. Results July 2026. @DrFionaTsang @NIHRresearch @hospitalcharity @DerbyRandD

We are excited to welcome five new sites who have joined ATNEC over the last few weeks! We look forward to working with you 👏 @DerbyRandD @WarwickCTU @amit_goyalx

Excited to speak at the Association of Breast Pathology Annual Meeting on 3 Oct 2025 in Birmingham! I’ll be sharing an update on axillary management in breast cancer. Join me there!

A very active summer for ATNEC, with 3⃣7⃣ registrations for June and 3⃣9⃣ registrations for July, with a total of 4⃣4⃣ randomisations! #thankyou to all of our sites 👏💙💜

The ATNEC team from WCTU were at the ABS conference in Birmingham in May 25, thank you for engaging with our poster. It was an insightful couple of days. 😀

A fantastic month in May for ATNEC with 2⃣7⃣ registrations and 2⃣6⃣ randomisations, keep up the excellent work screening and recruiting participants. #thankyou to all of our sites 👏💙

Another great month for the ATNEC trial with 3⃣1⃣ registrations and 2⃣0⃣ randomisations in April. Thank you to all our sites 💜👏

A fantastic two months for the ATNEC trial, with 3⃣2⃣ registrations and 2⃣5⃣ randomisations in Feb. We have continued this momentum in March, with 3⃣4⃣ registration and 2⃣0⃣ randomisations, making Q1 2025 the best quarter yet for randomisations🎉 #ThankYou to all our sites👏💜

📢#ATNEC has it's first international randomisation 🇮🇪 🌍 Thank you to @aoifelowery & the team at University Hospital Galway! 👏🍀 @RCSI_NSRSC @DerbyRandD @WarwickCTU @amit_goyalx

We have reached 1⃣0⃣0⃣0⃣ registrations to the ATNEC trial 🎉 A huge #ThankYou to all our recruiting sites and participants—this important milestone wouldn't have been possible without your incredible support 💜 #WellDoneTeams

A huge thank you to @tandgicft who have registered 3 patients today to the ATNEC trial! Thanks to all the Tameside Hospital research team 👏

A fantastic start to the year for the ATNEC trial ❄️ We've had 3⃣5⃣ registrations and 2⃣1⃣ randomisations in January, making it one of the best months for patient randomisations! Thank you to all our participating sites 👏

As we enter November, we wanted to reflect on the fantastic recruitment we saw last month! 🍂🎃 An incredible 4⃣2⃣ patients were registered in October with 2⃣0⃣ randomised, making it our best month yet for new patient enrolment! #ThankYou to all of of our recruiting sites!

Due to a radioisotope shortage, a single tracer is now permitted for #ATNEC. To maintain patient care and support @ATNEC1 participation, the team is temporarily allowing this interim measure.

Great to see involvement from our ATNEC patient advocate Jan Rose at this workshop @ICPVtweets @WarwickCTU

@ATNEC1 @RCSI_NSRSC @DerbyRandD @WarwickCTU @amit_goyalx Delighted to join this important study and provide our patients with the opportunity to participate. Thanks to all the ATNEC team for their support in getting to this point - looking forward to working with you!

For those attending the #Breastanbul conference today, don't miss Prof. Abeer Shaaban presenting the latest #ATNEC data on: 'Node Marking Techniques and TAD' - initial analysis from over 500 participants. 📍 Hall B at 17:15 @ #breastanbul2024 @NIHRresearch @amit_goyalx